In type 2 diabetes, SGLT2 inhibitors were linked to diabetic ketoacidosis vs. DPP-4 inhibitors.
| Title | In type 2 diabetes, SGLT2 inhibitors were linked to diabetic ketoacidosis vs. DPP-4 inhibitors. |
| Publication Type | Journal Article |
| Year of Publication | 2020 |
| Authors | Liakos, A., Tsapas A., & Bekiari E. |
| Journal | Ann Intern Med |
| Volume | 173 |
| Issue | 12 |
| Pagination | JC70 |
| Date Published | 2020 12 15 |
| ISSN | 1539-3704 |
| Keywords | Cohort Studies, Diabetes Mellitus, Type 2, Diabetic Ketoacidosis, Dipeptidyl-Peptidase IV Inhibitors, Glucose, Humans, Hypoglycemic Agents, Sodium, Sodium-Glucose Transporter 2 Inhibitors |
| Abstract | SOURCE CITATION: Douros A, Lix LM, Fralick M, et al. Ann Intern Med. 2020;173:417-25. 32716707. |
| DOI | 10.7326/ACPJ202012150-070 |
| Alternate Journal | Ann Intern Med |
| PubMed ID | 33316195 |
